| 注册
首页|期刊导航|中国临床药理学杂志|肿瘤分子靶向治疗药物的研究与应用进展

肿瘤分子靶向治疗药物的研究与应用进展

张伯阳 许重远

中国临床药理学杂志Issue(12):1213-1217,5.
中国临床药理学杂志Issue(12):1213-1217,5.DOI:10.13699/j.cnki.1001-6821.2015.12.039

肿瘤分子靶向治疗药物的研究与应用进展

Research and application progress on the molecular targeted drugs for cancer

张伯阳 1许重远1

作者信息

  • 1. 南方医科大学 南方医院 药物临床试验中心,广州 510515
  • 折叠

摘要

Abstract

The tumor molecular targeted drug family keeps developing and growing nowadays.Depending on specific target types,molecular targeted agents can be classified as cellular signal transduction inhibitors,angio-genesis inhibitors, apoptosis inducers and cell cycle inhibitors.The main categories of targeted therapy include large molecular compounds and small molecular compounds.Based on the number of targets, it can also be divided into single targeted drugs and multiple targeted drugs.This re-view aimed to analyze and summarize main molecular targeted drugs approved by FDA currently.

关键词

恶性肿瘤/靶向治疗/分子靶向药物

Key words

malignant tumor/targeted therapy/molecular targeted drug

分类

医药卫生

引用本文复制引用

张伯阳,许重远..肿瘤分子靶向治疗药物的研究与应用进展[J].中国临床药理学杂志,2015,(12):1213-1217,5.

基金项目

广州市科技计划基金资助项目 ()

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文